News

Tessara Therapeutics reinforces Advisory Board with the appointment of global industry leaders in 3D tissue models for drug discovery and cell therapies

Posted: 3 May 2022 Tessara Therapeutics, an Australian biotechnology company developing synthetic human brain micro-tissues as drug screening and neuro-regenerative medicine platforms, continues to ready itself for commercial entry with a series of high-profile Advisory Board appointments. Tessara…

Cancer Therapeutics CRC/Canthera Discovery win CRA Award for Research Commercialisation

Posted: 28 April 2022 Canthera Discovery is delighted to announce that its predecessor, Cancer Therapeutics CRC, received the Cooperative Research Australia (CRA) Excellence in Innovation Award for Research Commercialisation at an award ceremony at Parliament House in Canberra…

Presentation at the Lucust Walk Stem Cell Tx Conference

Posted: 8 April 2022 Event Date: 12 April 2022 Dr Ian Nisbet Chief Operating Officer Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner conference will explore stem cell therapeutics in the areas…

Cartherics CEO Alan Trounson ranked among the world’s most prominent scientists

Posted: 4 April 2022 The respected scientific platform Research.com has published the 2022 Edition of its Ranking of Top 1000 Scientists in the area of Biology and Biochemistry. BioMelbourne Network Member Cartherics welcomes the findings. In a notice…

2023 Australian Academy of Science Awards nominations closing soon

Posted: 4 April 2022 Nominations closing: 1 May 2022 Each year, the Australian Academy of Science shines a light on researchers who have made outstanding contributions to science, and in progressing the advancement of science in Australia, by…

Research Australia’s response to the Federal Budget

Posted: 31 March 2021 See below for BioMelbourne Network Member Research Australia’s response to the 2022/23 Federal Budget. The rising cost of living has become a key election issue and this Budget delivers cash payments, extends tax relief…

LaunchVic CEO wins Global Entrepreneurship Network Compass Award

Posted: 30 March 2022 BioMelbourne Network would like to congratulate LaunchVic CEO, Dr Kate Cornick, who has won the Global Entrepreneurship Network Compass Award. From LaunchVic We are incredibly proud of our CEO, Dr Kate Cornick who has…

AusBiotech’s AusBioNSW launched

Posted: 29 March 2022 AusBiotech is proud to launch AusBioNSW, a new peak industry membership body for NSW, to represent, connect, and promote NSW organisations doing business in and with the local, national and global life sciences economy.…

Almac Group support Agios’ road to FDA approval

Posted: 24 March 2022 BioMelbourne Network Member Almac Group is proud to confirm it has supported Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, in the clinical trial and rapid…

Neuren receives FDA approval

Posted: 23 March 2022 BioMelbourne Network Member, Neuren Pharmaceuticals, has received approval from the US Food and Drug Administration (FDA) to proceed with the Phase 2 trial of NNZ-2591 in PhelanMcDermid syndrome (PMS). The Investigational New Drug application…

Technovalia, Sypharma and BioNet announce Australian Vaccine Hub

Posted: 23 March 2022 Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines. Establishment of the first end-to-end Australian capability for product development and…

New national agency to advance genomic medicine welcomed

Posted: 22 March 2022 Australian Genomics Lead Professor Kathryn North says a new national agency to support genomic medicine will help propel the integration of genomics into mainstream healthcare, a transformative approach to patient diagnosis and treatment. She…

Home

News & opinion

Member Directory

Events